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Abstract
Background: We have already reported that TNF-a increases cardiomyocyte apoptosis and IL-10 treatment prevented these
effects of TNF-a. Present study investigates the role of Akt and Jak/Stat pathway in the IL-10 modulation of TNF-a induced
cardiomyocyte apoptosis.
Methodology/Principal findings: Cardiomyocytes isolated from adult Sprague Dawley rats were exposed to TNF-a (10 ng/
ml), IL-10 (10 ng/ml) and TNF-a+IL-10 (ratio 1) for 4 h. Exposure to TNF-a resulted in an increase in cardiomyocyte apoptosis
as measured by flow cytometry and TUNEL assay. IL-10 by itself had no effect, but it prevented TNF-a induced apoptosis. IL-
10 treatment increased Akt levels within cardiomyocytes and this change was associated with an increase in Jak1 and Stat3
phosphorylation. Pre-exposure of cells to Akt inhibitor prevented IL-10 induced Stat3 phosphorylation. Furthermore, in the
presence of Akt or Stat3 inhibitor, IL-10 treatment was unable to block TNF-a induced cardiomyocyte apoptosis.
Conclusion: It is suggested that IL-10 modulation of TNF-a induced cardiomyocyte apoptosis is mediated by Akt via Stat3
activation.
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Introduction
Proinflammatory cytokine tumor necrosis factor-a (TNF-a), has
been shown to have a cardiodepressent effect and is involved in
various cardiovascular complications [1,2]. Sustained long-term
over-expression of TNF-a provokes the induction of cardiomyo-
cyte apoptosis [3], which contributes to the pathophysiology of
several heart diseases, including dilated cardiomyopathy, myocar-
dial infarction, and heart failure [4,5]. Surprisingly, anti-TNF-a
therapy had no benefit or even had harmful effects in patients with
heart failure [6,7]. Thus identification of the intermediary steps
involved in the TNF-a induced cardiomyocyte apoptosis can offer
potential therapeutic targets to abrogate TNF-a induced cardio-
vascular diseases.
The anti-inflammatory cytokine interleukin-10 [IL-10], inhibits
the production of various pro-inflammatory cytokines including
TNF-a [8]. After binding to its receptors IL-10R1 or IL-10R2 on
the cell surface [9], IL-10 activates Jak/Stat pathway [10]. It has
also been reported that IL-10 activates ERK1/2 by inducing
tyrosine phosphorylation, therefore supporting cell survival and
cell protection [11].We have recently reported that TNF-a
increases cardiomyocyte apoptosis by activating p38 MAP kinase
and NFkB pathway and by down-regulating ERK 1/2 MAP
kinase [12,13]. IL-10 treatment prevented these effects of TNF-a
in isolated cardiomyocytes and we also found increased activation
of ERK1/2 MAPK upon IL-10 treatment [12]. However the
precise site of IL-10 action in this process is still unknown.
Akt, a serine-threonine kinase, regulates cellular metabolism, is
pro-survival and proliferative/growth effects. Among numerous
signaling pathways involved in the regulation of cellular apoptosis,
Akt plays a crucial role [14,15]. It is activated downstream of
phosphatidylinositol 3-kinase (PI3K) in response to stimulation of
receptor tyrosine kinases [16,17]. After activation, Akt is thought
to regulate pro-survival gene transcription through different
pathways [18,19]. It has been shown that IL-10 promotes the
survival of astrocytes by a mechanism that involves an activation of
PI 3-kinase [20]. In another report, it has been shown that IL-10
promotes survival of myeloid progenitors by activating Akt
pathway through the involvement of ERK 1/2 [21] and tyrosine
kinase [11]. Hence, in continuation to our recent study regarding
the role of ERK1/2 in IL-10 modulation of TNF-a induced effects
in cardiomyocyes, here we have investigated further downstream
signalling mechanisms involved in cardiomyocyte survival process.
Present study indicates that IL-10 modulates TNF-a induced
cardiomyocyte apoptosis by upregulating Akt via Stat3 phosphor-
ylation.
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The investigation conforms to the Guide for the Care and Use
of Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85-23, revised 1996). All animal-
experiment protocols were approved by the University of
Manitoba Animal Care Committee following the guidelines
established by the Canadian Council on Animal Care.
Isolation of adult ventricular cardiomyocytes
Cardiomyocytes were isolated from normal adult male Sprague
Dawley (SD) rats (250–300 g) using modified Langendorff
perfusion apparatus as described previously [22]. Cardiomyocytes
(1610
6 per well) were plated on laminin- coated polystyrene tissue
culture dishes. Plated cells were incubated in serum-free culture
medium M199 supplemented with antibiotics (streptomycin/
penicillin, 100 mg/ml) at 37uC under a 5% CO2-95% air
atmosphere. Two hours after plating, the culture medium was
changed to remove unattached dead cells and the viable
cardiomyocytes were incubated overnight under the same culture
conditions.
Treatment with cytokines
After initial incubation of 24 h, more than 90% of cardiomy-
ocytes were viable and these cells were treated with one of the
following; TNF-a (10 ng/ml), IL-10 (10 ng/ml), or combination of
TNF-a+IL-10 (ratio 1) and H2O2 (100 mM) for 4 h. Cardiomy-
ocytes were treated with 20 mmol/L of trolox for 30 min and then
incubated with the combination of trolox and TNF-a (10 ng/ml)
for 4 h. Hydrogen peroxide (H2O2) and trolox were used as
positive controls to mimic oxidative stress and antioxidant,
respectively [12,13]. In order to study the role of Akt and Stat 3
in the IL-10 regulation of TNF-a induced cardiomyocyte
apoptosis, cells were pretreated with 50 mM of LY294002
(PI3K/Akt inhibitor) or 50 mM of ‘5, 15 DPP’ (Stat 3 inhibitor)
or with DMSO (vehicle solution, at a final concentration of 0.01%)
for 30 min. These concentrations of inhibitors are based on our
pilot studies as well as manufacturer’s data sheet for IC 50 for each
inhibitor. After each inhibitor treatment, cells were washed three
times to remove any residual inhibitor that can interfere with
TNF-a or IL-10 treatment. The concentrations and time of
exposures for TNF-a and IL-10 are based on our earlier studies
[12,22].
Figure 1. Effects of H2O2 (100 mM), TNF-a (10 ng/ml), IL-10 (10 ng/ml), TNF-a+IL-10 (ratio 1), Trolox (20 mmol/L) and Trolox+TNF-a
on apoptosis and cell viability in adult rat cardiomyocytes. a) Representative dot plots of flow cytometric images of cardiomyocytes; b)
Quantitative analysis of apoptosis. Data are mean 6 SEM from 4 different experiments; c) Representative fluorescence microscopic images of
cardiomyocytes after TUNEL assay; and d) Percentage of viable cariomyocytes as assessed by trypan blue assay. *** Indicates significantly different
(p,0.001) from the respective control group; Significantly different (### p,0.001; ## P,0.01) when compared with TNF-a group.
doi:10.1371/journal.pone.0025009.g001
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Cell viability. Trypan blue exclusion method was used to
study the viability of the cardiomyocytes. Briefly, 0.4% trypan blue
was added directly to the cells suspended in PBS. Cells were
counted and expressed as percentage of viable cells.
Flow cytometry. The VybrantH Apoptosis assay kit # 7
(Molecular Probes, V-23201) was used to detect cardiomyocyte
apoptosis by flow cytometry (FACS Calibur, Becton Dickinson).
After different treatments, cardiomyocytes were washed with PBS
and adjusted the cell density to 1610
6 cells/ml in PBS. One
microlitre of YO-PRO-1 and propidium iodide (PI) was added
according to manufacturer’s guide. The mixture was incubated on
ice in the dark for 20 min. After staining with YO-PRO-1 and PI,
apoptotic cells show green fluorescence and dead cells show red
fluorescence. The fluorescence was measured by flow cytometry at
emission wavelengths ,530 and ,575 nm for the detection of
YO-PRO-1 and PI, respectively. Dot plot analysis was done for
20,000 events using Cell Quest Software (Bector Dickinson).
Terminal Deoxyribonucleotidytransferase mediated deo-
xyuridine triphosphate nick end labelling (TUNEL assay).
Cardiomyocyte apoptosis was also studied by TUNEL assay as
described previously [23,24]. Cells (10
5 cells/ml) from different
treatment groups were cultured in 8-well chamber slide and fixed
in 4% paraformaldehyde followed by digestion with proteinase K
(10 mg/ml) for 15 min at 37uC and permiabilization with 0.1%
triton X-100 for 5 min at 4uC. After washing twice with PBS,
cardiomyocytes were incubated with a mixture of 1 ml of Terminal
Deoxynucleotidyltransferase (TdT) enzyme and 4 ml of fluorescein
isothiocyanate (FITC) labelled 12dUTP in equilibrium buffer
(Genescript, USA). Cells were then assayed under fluorescence
microscope using excitation wavelength 450–500 nm and emission
wavelength 515–560 nm. Finally, TUNEL positive cells were
counted.
Western blot analysis
Whole-cell protein extracts prepared from control and treated
cardiomyocytes in different groups were suspended in PBS
containing protease inhibitor cocktail. Electrophoresis, immuno-
blotting, and protein detection were done for Jak1, Stat3, Akt, Bax
and Bcl-xl using specific antibody kits (Cell Signaling Technology,
Figure 2. Effects of TNF-a (10 ng/ml), IL-10 (10 ng/ml), TNF-a+IL-10 (ratio 1) on Akt phosphorylation in adult rat cardiomyocytes. a)
Upper panel, western blot analysis using specific Akt antibodies and b-actin as an internal control; Lower panel, densitometric analysis and the
values are ratios of phosphorylated to total Akt serine 473 (left panel) and threonine 308 (right panel); and b) Show Akt phosphorylation as measured
by cell based ELISA, values are normalized as relative fluorescence units (RFU’s). c and d) Immunofluorescence, cells were stained with phospho-Akt
antibody and secondary antibody Alexa Flour 555. Flourescein phalloidin was used to stain a-actinin. Representative fluorescence microscopic images
of cardiomyocytes (c). Quantification of the Akt expression. Data are expressed as mean6SEM from 4–6 different experiments (d). *p,0.01 and
***P,0.001 significantly different from the control group; ###p,0.001 significantly different when compared with TNF-a group.
doi:10.1371/journal.pone.0025009.g002
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Fluor S-MultiImager MAX system (Bio-Rad Laboratories,
Canada) and quantified by image analysis software (Quantity
One, Bio-Rad Laboratories, Canada).
Cell-Based ELISA for Akt phosphorylation
Phosphorylation of Akt (Ser473) was detected by using
fluorogenic substrates provided in the ELISA kit (R&D Systems)
according to manufacturer’s protocol. Briefly, cells were plated
and treated in the 96 well microplate, then fixed with 4%
paraformaldehyde in PBS. After blocking, cells were treated with
primary and then secondary antibodies. After incubation with the
substrate, fluorescence intensity in the plate was read using plate
reader with excitation at 540 nm and emission at 600 nm for
phosphorylated Akt in the cells. For total Akt, the plates were read
with excitation at 360 nm and emission at 450 nm.
Caspase-3 activity assay
Caspase-3 activity was measured by spectrofluorometric assay
using the fluoro-chrome 7-amino-4-methyl coumarin (AMC) and
substrate DEVD-AMC, provided in the CaspACE
TM assay system
(Promega Corp. Madison, USA). The assay was performed in 96
well polystyrene plates (Becton Dickinson, USA). From each
treatment group 100 mg of protein was added to the reaction wells,
together with 32 ml of caspase assay buffer, 2 ml DMSO, 10 mlo f
dithiothreitol and 2 ml of DEVD-AMC substrate (dissolved in
DMSO). The reaction mixture was incubated at 30uC for
60 minutes and thereafter analyzed for AMC fluorescence using
spectrofluorometer (Spectra Max Gemini, USA) at 360 nm
excitation and 460 nm emission. The fluorescence data were
corrected by subtracting background values.
Immunofluorescence
Cardiomyocytes after different treatments were fixed with 4%
paraformaldehyde. For localization of Akt, cells were stained
overnight with rat anti phospho-Akt antibody (Cell Signalling
Technology, USA; 1:40) and then secondary antibody Alexa
FluorH 555 (Invitrogen Inc., USA; 1:250) for 3 hours. Simulta-
neously, for actin filaments, cells were stained with fluorescein
phalloidin (Molecular Probes). After secondary labelling cells were
washed with PBS and fixed with ProLongH Gold antifade reagent.
The fluorescence signals were examined using Fluorescence
microscope (Olympus, Japan).
Protein and Statistical analysis
Total protein concentration was determined using bovine serum
albumin as a standard [25]. Data are expressed as the mean 6
SEM. Groups were compared by one-way ANOVA and
Bonferroni’s test was performed to identify differences between
groups. Value of p,0.05 was considered significant.
Results
Cardiomyocyte apoptosis and viability
Cardiomyocyte apoptosis and viability were studied by flow
cytometry and TUNEL assay (Figs. 1a–d). Exposure to TNF-a
resulted in an increase in apoptosis. Treatment with IL-10 alone
did not show any significant change, whereas TNF-a induced
Figure 3. Effects of TNF-a (10 ng/ml), IL-10 (10 ng/ml) and TNF-a+IL-10 (ratio 1) on apoptosis in adult rat cardiomyocytes after Akt
inhibition. Cells were pretreated with 50 mM of PI3K/AKT inhibitor LY294002 (LY) for 30 minutes. a) Representative dot plots of flow cytometric
images of 20,000 events. b) Quantification of the level of apoptosis using YO-PRO. Data are mean 6 SEM from 4 different experiments. Significantly
different (***p,0.001) from the control group containing 0.01% DMSO.
doi:10.1371/journal.pone.0025009.g003
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prevented by IL-10 treatment. H2O2 treatment, used as a positive
control for oxidative stress, also increased the level of apoptotic
cells as compared to untreated cells. Antioxidant trolox signif-
icantly prevented the TNF-a-induced cardiomyocyte apoptosis.
Trolox by itself had no effect.
TNF-a exposure to cardiomyocytes significantly decreased the
cell viability. IL-10 treatment prevented TNF-a induced decrease
in cell viability. H2O2 also led to a significant decrease in
cardiomyocyte viability and antioxidant trolox prevented the
TNF-a-induced decrease in cardiomyocyte viability (Fig. 1d).
Effects of TNF-a and IL-10 on Akt phosphorylation
Akt, a serine/threonine kinase, once activated within the cell,
regulates the transcription of several pro-survival genes. We
examined the phosphorylation of Akt in the cardiomyocytes
exposed to TNF-a (10 ng/ml), IL-10 (10 ng/ml) and IL-10+TNF-
a (ratio 1) at serine 473 and threonine 308 sites. Exposure to TNF-
a did not cause any change in Akt phosphorylation as measured by
Western blot and cell-based ELISA (Figs. 2a and b). IL-10
treatment significantly (p,0.001) increased Akt phosphorylation at
both serine 473 (Fig. 2a, lower left panel) and threonine 308 sites
(Fig. 2a, lower right panel) and this positive effect of IL-10 was also
seen in the presence of TNF-a. Immunofluorescence measure-
ments (Figs. 2c and d) complemented the above findings seen with
Western blot and ELISA (Figs. 2a and b).
Inhibition of Akt pathway
In order to study the role of Akt pathway in the IL-10 regulation
of TNF-a induced cardiomyocyte apoptosis, we pre-exposed
cardiomyocytes to PI3K/Akt inhibitor (LY294002) and then
treated the cells with TNF-a and IL-10 and checked the level of
apoptosis. In Akt inhibited cells, IL-10 treatment failed to block
the TNF-a induced cardiomyocyte apoptosis (Figs. 3a and b) as
seen in presence of TNF-a+IL10 (Fig. 1b). In studies employing
different inhibitors dissolved in DMSO (0.01%), the controls were
also supplemented with this vehicle.
TNF-a caused an increase in the ratio of Bax/Bcl-xl and
caspase-3 activation and IL-10 treatment of cardiomyocytes
blocked this effect of TNF- a (Figs. 4a and b). Furthermore, we
observed that in cardiomyocytes pre-treated with Akt inhibitor,
TNF-a caused an increase in both Bax/Bcl-xl ratio and caspase
activity and IL-10 was not able to prevent these TNF-a induced
changes (Figs. 4c and d). To confirm whether PI3K inhibitor,
Figure 4. Effects of TNF-a (10 ng/ml), IL-10 (10 ng/ml), and TNF-a+IL-10 (ratio 1). on Bax/Bcl-xl ratio and caspase-3 activity in adult
rat cardiomyocytes (a & b). a) Bax/Bcl-xl data, Upper panel: Western blot analysis using specific Bax, Bcl-xl antibody and b-actin was used as an
internal control; Lower panel: Shows densitometric analysis of Bax/Bcl-xl. b) Caspase-3 activity as measured in terms of flouro-chrome, amino
methyl coumarin (AMC), liberated in the fluorometric assay system (CaspACE
TM). Bax/Bcl-xl ratio and caspase-3 activity after Akt inhibition (c&d ).
Cells were pretreated with 50 mM of PI3K/AKT inhibitor LY294002 (LY) for 30 minutes. c) Upper panel: Western blot analysis using specific Bax, Bcl-xl
antibody and b-actin was used as an internal control; Lower panel: Shows densitometric analysis. d) Caspase-3 activity. Data are expressed as
mean6SEM from 4–6 different experiments. Significantly different (***p,0.001) from control; $$$p,0.001 vs respective TNF-a group; ###p,0.001
vs respective LY+IL-10 group. In figure 4c and d, the control had 0.01% DMSO.
doi:10.1371/journal.pone.0025009.g004
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incubated with 50 mM of LY294002 for 30 min and Akt
expression was measured. Treatment with LY294002 inhibited
IL-10 induced Akt phosphorylation (data not shown).
Involvement of Jak/Stat pathway
IL-10 after binding to its receptors on the cell surface activates
Jak/Stat pathway that further up-regulates several nuclear
transcription factors involved in cell survival. We have investigated
whether IL-10 mediated activation of Akt is involved in cell
survival through Jak/Stat pathway. We examined the Jak1 and
Stat3 phosphorylation in cardiomyocytes exposed to TNF-a
(10 ng/ml), IL-10 (10 ng/ml) and TNF-a+IL-10 (ratio 1).
Exposure to TNF-a did not cause any change in Jak1 and Stat3
phosphorylation (Figs. 5a, b, and c). While, IL-10 treatment,
significantly (p,0.001) increased the Jak1 and Stat3 phosphory-
lation as compared to control, as well as TNF-a. This IL-10-
induced increase in Jak1 and Stat3 phosphorylation was also seen
in the presence of TNF-a (P,0.001).
In cardiomyocytes pre-treated with Akt inhibitor, we still
observed IL-10 induced significant increase in Jak1 phosphoryla-
tion which was also seen in the presence of TNF-a (Figs. 5d and e).
However, Akt inhibitor did prevent IL-10 induced increase in Stat
3 phosphorylation (Figs. 5d and f). To further investigate the direct
role of Stat3 in the interplay of TNF-a and IL-10 in regulating
cardiomyocyte apoptosis, the level of apoptosis was checked in the
presence of Stat3 inhibitor (5, 15 DPP). We observed that in Stat3
inhibited cells, IL-10 treatment was not able to prevent TNF-a
induced cardiomyocyte apoptosis and cell viability (Fig. 6a and b).
Discussion
Earlier we have reported that TNF-a induces cardiomyocyte
apoptosis and this effect is mediated by an increase in oxidative
stress [12,13]. Furthermore, IL-10 was shown to mitigate this
effect via its antioxidant ability as well as an increase in ERK1/2
MAPK activity [12,13]. It is also known that JAK/Stat and PI3K/
Akt provide resistance against oxidative stress (caused by H2O2)a s
well as apoptosis in neonatal rat cardiomyocytes [26]. It was
Figure 5. Jak1 and Stat3 phosphorylation in adult rat cardiomyocytes after treatment with TNF-a (10 ng/ml), IL-10 (10 ng/ml) and
TNF-a+IL-10 (ratio 1) with or without pretreatment of PI3K/Akt inhibitor Ly294002 (LY) for 30 min. Western blot (a&d ) and
densitometric analysis to calculate the ratio of phosphorylated to total, Jak1 (b&e ) and Stat3 (c&f ) expression. The relative levels of protein
expression were normalized to b-actin used as an internal control. Data are expressed as mean6SEM from 4–6 different experiments. Significantly
different (***p,0.001) from respective control; ###p,0.001 vs. respective TNF-a group. In figure 5d, e and f, the control had 0.01% DMSO.
doi:10.1371/journal.pone.0025009.g005
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higher levels of Akt and Stat3, respectively in neonatal rat
cardiomyocytes [26]. The present study examines this downstream
signalling mechanism in adult rat cardiomyocytes and the data
show that this beneficial effect of IL-10 may involve an
upregulation of Akt phosphorylation that activates the transcrip-
tion factor Stat-3.
Apoptosis plays a key role in the pathogenesis of cardiovascular
disease due to loss of terminally differentiated cardiomyocytes.
The pro-apoptotic role of TNF-a has been extensively investigated
in a variety of in vitro and in vivo models [12,13,14,27]. TNF-a
causes apoptotic cell death by two different but interrelated
pathways [28]. First, by binding to its cell surface receptors, TNF-
a triggers apoptotic signalling through caspase-3 activation and
causes apoptosis (extrinsic pathway). Second, TNF-a can also
stimulate apoptosis as a result of overproduction of reactive oxygen
species and mitochondrial injury (intrinsic pathway). In this
regard, we have previously reported that direct exposure of
cardiomyocytes to TNF-a led to an increase in the production of
reactive oxidative species and an increase in oxidative stress [12].
Such an increase in oxidative stress disturbs the balance between
anti- and pro-apoptotic proteins of Bcl-2 family, thus disrupting
the mitochondrial membrane potential and inducing the release
of cytochrome c and finally leading to apoptosis. Anti-TNF-a
therapies in patients with heart failure were not effective, a precise
reason for this is unknown [6,7,29].
IL-10, an anti-inflammatory cytokine, inhibits the production of
several pro-inflammatory cytokines including TNF-a. An imbal-
ance between IL-10 and TNF-a causes cell injury and an increase
in oxidative stress in isolated cardiomyocytes [30,31]. In an in-vivo
study in rats, it has been observed that the progression of
experimentally induced heart failure subsequent to myocardial
infarction was associated with a decrease in IL-10/TNF-a ratio
[19,21]. Patients with advanced congestive heart failure (New
York Heart Association Class III and IV) also showed low IL-10 to
TNF-a ratio [32]. These observations provide evidence that
improved heart function is associated with improved IL-10/TNF-
a ratio [22,30]. TNF-a induced cardiomyocyte apoptosis, in the
present study, was significantly decreased by IL-10 treatment. Pro-
apoptotic effects of TNF-a have been shown to be modulated by
Figure 6. Effects of H2O2 (100 mM), TNF-a (10 ng/ml), IL-10 (10 ng/ml), and TNF-a+IL-10 (ratio 1), on apoptosis in adult rat
cardiomyocytes after Stat3 inhibition. Cells were pretreated with 50 mM of Stat3 inhibitor (5,15DPP) for 30 minutes and for the control cells the
medium contained 0.01% DMSO. Fluorescence microscopic images of cardiomyocytes after TUNEL assay are representative from 3 different
experiments. Images were taken at 206magnification and further enlarged to 2106210 pixels. b) Percentage of viable cardiomyocytes as assessed
by trypan blue assay. ***) Indicates significantly different (p,0.001) from the respective control group; ###) significantly different (p,0.001) as
compared with respective IL-10 and TNF-a+IL-10 no-inhibitor group.
doi:10.1371/journal.pone.0025009.g006
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human articular chondrocytes, IL-10 upregulated bcl-2 expression
and down-regulated TNF-a induced caspase-3 activity, thus
decreased the level of apoptosis [33]. The intracellular mechanism
by which IL-10 generates survival signals and mediates its anti-
inflammatory effects remains largely unknown. In this study, we
show an involvement of Akt, a serine/threonine kinase, in the
protective role of IL-10 in TNF-a induced cardiomyocyte
apoptosis.
Akt, also known as protein kinase B, has emerged as a focal
point for signal transduction pathways responsible for cell
survival, energy metabolism and protein synthesis [14]. In
cardiomyocytes, Akt prevents apoptosis due to ischemia reperfu-
sion [16,34], volume and/or pressure overload and hypoxia [17].
Several drugs, beneficial to heart patients, are known to act
through Akt signalling [35]. It has been reported that amlodipine
improves cardiac function through the activation of Akt pathway
and by inhibiting the level of TNF-a [35]. In the present study,
exposure to TNF-a did not cause any significant change in Akt
phosphorylation. However, IL-10 treatment by itself caused a
significant increase in Akt phosphorylation and TNF-a exposure
did not affect this IL-10 induced increase. In order to further
investigate, whether IL-10 regulates TNF-a induced cardiomy-
ocyte apoptosis through Akt mediated cell survival pathway, we
pre-exposed the cells to PI3K/Akt pathway inhibitor (LY-
294002) and examined the effects of TNF-a and IL-10 on
cardiomyocyte apoptosis. In LY-294002 treated cells, IL-10
treatment was not able to block TNF-a induced caspase-3
activation and cardiomyocyte apoptosis. These data suggest that
Akt mediates IL-10 regulation of TNF-a induced cardiomyocyte
apoptosis.
Regulation of intracellular apoptotic processes by Akt is
mediated through the Bcl-2 family of proteins. It has been
reported that leukemia inhibitory factor (LIF) prevented doxoru-
bicin induced cardiomyocyte apoptosis by activating PI3K/Akt
that further maintained Bcl-xl level [36]. Another Bcl-2 family
protein regulated by Akt is the proapoptotic BH1-3 protein, Bax,
which is a key molecule in mitochondrial outer membrane
permeabilization [37]. Akt inhibits Bax activation and apoptosis in
a PI3K-dependent manner [18]. In the present study, Akt also
mediated the IL-10 regulation of TNF-a induced cardiomyocyte
apoptosis by preventing an increase in the ratio of Bax and Bcl-xl.
Furthermore, in LY-294002 treated cells, IL-10 treatment was not
able to prevent TNF-a induced increase in the ratio of Bax/Bcl-xl.
It is now well accepted that IL-10, after binding to its receptors
on the cell surface, activates Jak/Stat pathway. In the present
study, TNF-a exposure did not cause any change in Jak1 and
Stat3 phosphorylation. Whereas, IL-10 treatment significantly
increased both Jak1 and Stat3 phosphorylation. When cardiomy-
ocytes were pre-treated with PI3K/Akt inhibitor (LY294002), IL-
10 treatment failed to increases Stat3 phosphorylation. In this
regard, Stat3 phosphorylation has also been reported to occur
through other members of the Janus family of non-receptor
tyrosine kinases [35,36,37]. We have also observed that Akt
inhibition in the present study could not block IL-10 induced
increase in Jak1 phosphorylation. Furthermore in the presence of
Stat3 inhibitor IL-10 treatment was not able to prevent TNF-a
induced apoptosis and cell viability was decreased. Thus, this study
provides evidence that TNF-a induced cardiomyocyte apoptosis is
mitigated by IL-10 treatment via the up-regulation of Akt
phosphorylation that further increases Stat3 phosphorylation
independent of JAK1 activation.
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